📰 Opgn News
Page 5 - Opgn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Opgn. Real-time updates on events, politics, business and more.
May 11, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 206,100 shares, an increase of 127.0% from the April 15th total of 90,800 shares. Approximately 3.8% of the shares of the stock are short sold. […]
April 15, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 303,400 shares, a drop of 44.4% from the March 15th total of 545,300 shares. Based on an average daily volume of 456,500 shares, the short-interest ratio is currently 0.7 days. Currently, […]
April 4, 2023
StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) to a sell rating in a report released on Friday morning. OpGen Stock Performance NASDAQ:OPGN opened at $1.33 on Friday. The firm has a market cap of $3.56 million, a PE ratio of -0.09 and a beta of -0.22. OpGen has a fifty-two week low of […]
April 1, 2023
OpGen (NASDAQ:OPGN – Get Rating) was upgraded by research analysts at StockNews.com to a “sell” rating in a report released on Friday. OpGen Stock Performance OpGen stock traded up $0.15 during midday trading on Friday, reaching $1.33. 218,966 shares of the stock traded hands, compared to its average volume of 485,159. The company has a […]
April 1, 2023
OpGen (NASDAQ:OPGN – Get Rating) was upgraded by analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Friday. OpGen Stock Performance OpGen stock traded up $0.15 during mid-day trading on Friday, reaching $1.33. The company’s stock had a trading volume of 218,966 shares, compared to its average […]
March 30, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Rating) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 545,300 shares, a growth of 272.5% from the February 28th total of 146,400 shares. Based on an average daily volume of 446,000 shares, the short-interest ratio is currently 1.2 days. Approximately […]
March 28, 2023
OpGen, Inc. (NASDAQ:OPGN – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 545,300 shares, an increase of 272.5% from the February 28th total of 146,400 shares. Based on an average daily volume of 446,000 shares, the days-to-cover […]
September 14, 2022
Investment analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Rating) in a report released on Wednesday. The brokerage set a “sell” rating on the medical research company’s stock. A number of other research firms have also issued reports on OPGN. Alliance Global Partners lowered OpGen to a “neutral” rating in a […]
June 22, 2022
OpGen (NASDAQ: OPGN) has recently received a number of price target changes and ratings updates: 6/18/2022 – OpGen is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/10/2022 – OpGen is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/10/2022 – OpGen had […]
June 4, 2022
Several brokerages have updated their recommendations and price targets on shares of OpGen (NASDAQ: OPGN) in the last few weeks: 6/3/2022 – OpGen was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping […]